SEC Form 4/A · accession 0001177648-16-000027
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Tim Ocain
Officer — Senior Vice President
Period of report
Nov 20, 2015
Accepted (ET)
Nov 22, 2016 · 6:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $31.42 | Nov 20, 2015 | A | 25,500 | A | — | Nov 20, 2025 | Common Stock | 25,500 | 25,500 | D |
Explanation of responses
- F1Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2015).
- F2This Form 4 is being amended to correct the original Form 4 filing by amending the expiration date of the granted stock option from "11/20/2014" to "11/20/2025". This amendment corrects an administrative error.